Aptevo Therapeutics (APVO) Tops Q2 EPS by 3c

August 9, 2019 9:02 AM

Aptevo Therapeutics (NASDAQ: APVO) reported Q2 EPS of ($0.30), $0.03 better than the analyst estimate of ($0.33). Revenue for the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found